Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.2 PLN | -3.01% |
|
-0.98% | -23.49% |
16/07 | ORIC Pharmaceuticals, Inc. Enters into Clinical Trial Collaboration and Supply Agreements with Bayer and Janssen Research & Development, LLC | CI |
15/07 | BAYER AG : UBS sticks Neutral | ZD |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
856B | ||||||
631B | ||||||
359B | ||||||
325B | ||||||
297B |
- Stock Market
- Equities
- BAYN Stock
- BAY Stock
- Charts Bayer AG
- Sector Chart